Response Genetics Profit Margin

Response Genetics (RGDXQ) currently reports a profit margin of -89.33% as of March 2015. That compares with -58.2% in the prior-year period — down 53.5% year over year. That is below the sector sector average of 21.36%. Use the charts on this page to explore Response Genetics's profit margin history and peer comparisons.

Response Genetics's profit margin decreased from -58.2% to -89.33% — a 53.5% year-over-year decrease (period ending March 2015). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Response Genetics's profit margin of -89.33% is lower than the its sector sector average of 21.36%. That is roughly 518.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Response Genetics's current -89.33% should be judged against industry norms (sector average: 21.36%) and against RGDXQ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -89.33%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 21.36%. From there, open related valuation or income-statement pages for Response Genetics, and consider following RGDXQ for alerts when major investors trade the stock.